Novartis logo
Novartis
NVS | NYSE
Chart Builder DCF Calculator
$160.20
-$0.30 (-0.19%)
At close: Nov 16, 2026, 4:00 PM ET
$160.20
$0.00 (0.00%)
After-hours: Nov 16, 2026, 4:00 PM ET

Novartis Company Profile

Company profile explained

Company Profile

Novartis AG is a holding company, which engages in the business of developing, manufacturing, and marketing healthcare products. Its product portfolio is heavily focused on innovative prescription medicines, especially oncology, immunology, neuroscience, and cardiovascular diseases, supplemented by established older brands and a wide range of specialized therapies. The company was founded on February 29, 1996 and is headquartered in Basel, Switzerland.

Key Executives

Name Position
Vasant Narasimhan Chief Executive Officer
Mukul Mehta Chief Financial Officer
Evan Beckman Global Head of Translational Medicine at Novartis Institute for BioMedical Research
Karen L. Hale Chief Legal & Compliance Officer
Patrick Horber President of International
Paul Penepent Head of Group Financial Reporting and Accounting
Robert Kowalski Chief People & Organization Officer
Sloan Simpson Global Head of Investor Relations
Steffen Lang President of Operations
Victor Bulto President of US

Latest SEC Filings

Date Type Title
Oct 27, 2026 SC 13G/A [Amend] Statement of acquisition of beneficial own...
Oct 27, 2026 6-K Filing
Sep 08, 2026 6-K Filing
Sep 04, 2026 6-K Filing
Sep 01, 2026 6-K Filing
Jul 21, 2026 6-K Filing
Jun 11, 2026 6-K Filing
Apr 28, 2026 6-K Filing
Mar 18, 2026 6-K Filing
Mar 17, 2026 424B5 Filing
View All SEC Filings ➞
Novartis
Novartis logo
Country Switzerland
IPO Date Nov 7, 1996
Industry Drug Manufacturers - General
Sector Healthcare
Employees 75,267
CEO Vasant Narasimhan

Contact Details

Lichtstrasse 35 Basel, BS 4056 Switzerland

Stock Details

Ticker Symbol NVS
Exchange NYSE
Fiscal Year January - December
Reporting Currency USD
CIK Code 0001114448
CUSIP Number 66987V109
ISIN Number US66987V1098
SIC Code 2834

© 2026 bestshares.com. All rights reserved.

All data is for informational purposes only. bestshares.com is not a broker, dealer, or registered investment adviser, and nothing on this site is a recommendation to buy or sell any security.